Lyrica Capsule 75 mg (Pregabalin)

Adult dose

This medication is taken orally in divided doses twice daily, regardless of food. The starting dose for neuropathic pain (peripheral and central), epilepsy, and fibromyalgia treatment is 150 mg per day; depending on individual response and tolerability, it can be increased to 300 mg per day after 3 to 7 days or one week. If needed, it can be increased to a maximum of 600 mg per day. Recommended dosage for fibromyalgia.

Child dose

Use is not recommended for children under 12 years or adolescents aged 12-17 years due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors, so patients should consult a doctor immediately if they experience any changes in mood or behavior during treatment. Patients with hypersensitivity to this medication should not take it, and diabetic patients may need to adjust their diabetes management medications due to weight gain. If symptoms of angioedema occur, use should be discontinued immediately, and elderly patients should be cautious of dizziness or drowsiness to avoid falls or injuries. Transient visual disturbances or changes in vision may occur, and symptoms may improve upon discontinuation of the drug. When switching to this medication from existing antiepileptic drugs, it should be done cautiously as there is insufficient data regarding discontinuation of those medications. Discontinuation should not be abrupt, as withdrawal symptoms like insomnia, headaches, nausea, and anxiety may occur, thus it should be tapered gradually per a doctor's instructions. Due to the risk of drug abuse, patients with a history of mental illness or substance abuse should be closely monitored. Dose adjustments may be necessary for patients with impaired renal function, and caution should be exercised if administered to patients with heart failure. Concurrent use with opioid analgesics may exacerbate central nervous system depression, so caution is needed. Pregnant women are advised against using this medication during the early stages of pregnancy due to potential fetal impact, and women of childbearing potential should employ effective contraception. Dizziness or drowsiness may occur while taking this medication, so patients should refrain from engaging in dangerous activities like driving or operating machinery. Rarely, serious life-threatening skin reactions may occur; if any skin abnormalities appear, use should be immediately discontinued, and a physician should be notified. In case of overdose, symptoms such as confusion, drowsiness, and depression may arise, necessitating urgent medical treatment. Keep out of reach of children, and it is advisable to avoid transferring to another container.

Serious side effects

Hives, severe swelling (edema), shortness of breath, difficulty breathing, jaundice (yellowing of skin or eyes), sudden and severe headaches, seizures, confusion of consciousness, paralysis, markedly reduced urine output, edema accompanied by raised blood pressure, severe allergic reactions, severe skin adverse reactions, serious neurological symptoms, severe edema or urination abnormalities, angioedema, loss of consciousness, psychiatric disorders, symptoms resembling anaphylaxis, skin

Mild side effects

• Dizziness
• drowsiness
• increased appetite
• loss of appetite
• hypoglycemia
• confusion
• disorientation
• irritability
• depression
• euphoria

This medication should be kept in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain the storage temperature between 15 and 30 degrees Celsius. This helps to preserve the effectiveness of the medication.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part containing white or pale yellow powder.

Package unit

30 capsules/bottle